McElhenny Sheffield Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$261K Buy
+675
New +$250K 0.06% 82
2026
Q1
Sell
-607
Closed -$213K 100
2025
Q4
$213K Buy
+607
New +$205K 0.05% 96
2025
Q3
Sell
-560
Closed -$218K 112
2025
Q2
$218K Sell
560
-3
-0.5% -$1.21K 0.06% 97
2025
Q1
$245K Buy
563
+3
+0.5% +$1.2K 0.09% 93
2024
Q4
$207K Sell
560
-986
-64% -$413K 0.07% 100
2024
Q3
$804K Sell
1,546
-41
-3% -$21.9K 0.26% 24
2024
Q2
$860K Sell
1,587
-62
-4% -$32.8K 0.3% 22
2024
Q1
$855K Sell
1,649
-58
-3% -$28.8K 0.3% 23
2023
Q4
$805K Buy
1,707
+1,147
+205% +$530K 0.33% 26
2023
Q3
$244K Hold
560
0.12% 82
2023
Q2
$249K Hold
560
0.11% 81
2023
Q1
$257K Sell
560
-5
-0.9% -$2.38K 0.14% 78
2022
Q4
$290K Buy
565
+5
+0.9% +$2.54K 0.13% 65
2022
Q3
$254K Hold
560
0.19% 70
2022
Q2
$270K Hold
560
0.13% 78
2022
Q1
$275K Hold
560
0.1% 95
2021
Q4
$260K Hold
560
0.1% 106
2021
Q3
$209K Buy
+560
New +$213K 0.09% 113

Other funds holding ELV

McElhenny Sheffield Capital Management's ELV Position: Q2 2026 in Review

McElhenny Sheffield Capital Management opened a new position in Elevance Health (ELV) in Q2 2026: 675 shares worth $261K. The stake represents 0.06% of the portfolio and ranks #82 among its holdings. This is a return to the name: McElhenny Sheffield Capital Management previously reported a position in ELV as recently as Q4 2025.

McElhenny Sheffield Capital Management first reported a position in ELV in Q3 2021 and has held it in 18 quarters since. The position peaked at $860K in Q2 2024. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • McElhenny Sheffield Capital Management held 675 shares of Elevance Health worth $261K as of Q2 2026.
  • Elevance Health was a new McElhenny Sheffield Capital Management position in Q2 2026.
  • Elevance Health made up 0.06% of McElhenny Sheffield Capital Management's portfolio in Q2 2026, its #82 holding.
  • McElhenny Sheffield Capital Management first reported a position in Elevance Health in Q3 2021 and has held it in 18 quarters since.
  • McElhenny Sheffield Capital Management's Elevance Health position peaked at $860K in Q2 2024.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on McElhenny Sheffield Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.